The aim of the present study was to assess the status of ET-1 receptor subtypes (ETA and ETB) in ventricular myocytes and fibroblasts and to determine the role of PKC-dependent pathways in ET-1-stimulated cardiac cells in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Systolic blood pressure and relative heart to body weight were significantly increased in DOCA-salt rats, In unilaterally nephrectomized (Uni-Nx) control rats, more than 90% of cardiomyocyte ET receptors were of the ETA subtype, whereas in fibroblasts ETA and ETB receptors were present in a 1:3 ratio, In DOCA-salt rats, the density of the ETA receptor subtype was reduced by 31% in cardiomyocytes and in cardiac fibroblasts only ETB receptor density was decreased by 29%. Affinity was unchanged. The relative expression of immunoreactive PKC alpha, gamma and epsilon was significantly increased, whereas PKC delta was not altered in cardiac extracts of DOCA-salt rats. In cardiac fibroblasts from DOCA-salt rats PKC delta was significantly increased and PKC epsilon was not translocated after ET-1 stimulation. The hearts of DOCA-salt hypertensive rats are thus characterized by: (1) decreased density of cardiomyocyte ETA receptors and fibroblast ETB receptors; (2) cell-specific enhanced expression of some PKC isoenzymes (alpha, alpha, delta and epsilon): and (3) unresponsiveness of PKC epsilon to translocate in the presence of ET-1. Together with alterations of ET-1-induced Ca2+ handling in cardiac myocytes and fibroblasts, which we previously reported, results from the present study indicate a marked modification of the cardiac ET-1 system of DOCA-salt hypertensive rats. (C) 2000 Academic Press.
机构:
Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, BrazilUniv Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil
Tostes, RCA
David, FL
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, BrazilUniv Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil
David, FL
Carvalho, MHC
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, BrazilUniv Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil
Carvalho, MHC
Nigro, D
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, BrazilUniv Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil
Nigro, D
Scivoletto, R
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, BrazilUniv Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil
Scivoletto, R
Fortes, ZB
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, BrazilUniv Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil
机构:
NAGOYA CITY UNIV, SCH MED,DEPT INTERNAL MED 2,MIZUHO KU, NAGOYA, AICHI 467, JAPANNAGOYA CITY UNIV, SCH MED,DEPT INTERNAL MED 2,MIZUHO KU, NAGOYA, AICHI 467, JAPAN
FUJIMOTO, S
DOHI, Y
论文数: 0引用数: 0
h-index: 0
机构:
NAGOYA CITY UNIV, SCH MED,DEPT INTERNAL MED 2,MIZUHO KU, NAGOYA, AICHI 467, JAPANNAGOYA CITY UNIV, SCH MED,DEPT INTERNAL MED 2,MIZUHO KU, NAGOYA, AICHI 467, JAPAN
DOHI, Y
AOKI, K
论文数: 0引用数: 0
h-index: 0
机构:
NAGOYA CITY UNIV, SCH MED,DEPT INTERNAL MED 2,MIZUHO KU, NAGOYA, AICHI 467, JAPANNAGOYA CITY UNIV, SCH MED,DEPT INTERNAL MED 2,MIZUHO KU, NAGOYA, AICHI 467, JAPAN
AOKI, K
MATSUDA, T
论文数: 0引用数: 0
h-index: 0
机构:
NAGOYA CITY UNIV, SCH MED,DEPT INTERNAL MED 2,MIZUHO KU, NAGOYA, AICHI 467, JAPANNAGOYA CITY UNIV, SCH MED,DEPT INTERNAL MED 2,MIZUHO KU, NAGOYA, AICHI 467, JAPAN
MATSUDA, T
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,
1988,
244
(02):
: 716
-
723